PAHC
Phibro Animal Health Corp
Phibro Animal Health Corp historical holders
total: 2
Polen Capital Management Phibro Animal Health Corp transactions over time
- Total transactions:
- 1
- New positions:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q1
Polen Capital Management has been an institutional investor in Phibro Animal Health Corp (PAHC) since 2026 Q1. According to 2026 Q1 report, Polen Capital Management holds 6,775 shares with a market value of roughly $374.72K representing 0.00% of their equity portfolio. The fund/company first acquired PAHC in 2026 Q1, initially purchasing 6,775 shares.
Does Polen Capital Management still hold PAHC?
Yes, Polen Capital Management continues to hold Phibro Animal Health Corp (PAHC). According to their 2026 Q1 report, they maintain a position of 6,775 shares valued at approximately $374.72K, representing 0.00% of their equity portfolio.
When did Polen Capital Management first invest in PAHC?
Polen Capital Management first invested in Phibro Animal Health Corp (PAHC) in 2026 Q1 at the reported quarter-end price of $55.31 per share, acquiring 6,775 shares in their initial purchase.
What is Polen Capital Management's average cost basis for PAHC?
Based on historical transaction data, Polen Capital Management's estimated cost basis for Phibro Animal Health Corp (PAHC) is approximately $55.31 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $55.31
PAHC transactions history by Polen Capital Management
1 result
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.00%
|
6,775
|
$55.31
|
$374,725
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.